Monday, 9th November
8th Australasian Vaccines & Immunotherapeutics Development Meeting 2020
Days
Monday, 9th November
Tuesday, 10th November
Search
Speakers
Welcome and Official Opening
10:50AM - 11:00AM
Monday, 9th November
Chair: Ian Barr
Session1: COVID-19
11:00AM - 12:00PM
Monday, 9th November
Chairs: Lisa Ng & Ian Barr
Sponsored by:
CSL Innovation Pty Ltd
Emerging bat viruses in the context of the COVID-19 pandemic
-
Linfa Wang
SARS-CoV-2 and its transmission
-
Leo Poon
Molecular clamp stabilized subunit vaccine for COVID-19
-
Keith Chappell
Break
12:00PM - 12:10PM
Monday, 9th November
Session 2: Emerging Diseases
12:10PM - 1:10PM
Monday, 9th November
Chairs: Laurent Renia & Gabrielle Belz
Analysis of SARS-CoV-2 in clinical samples, post-mortem tissue and animal models and what this tells us about COVID-19 in severe cases
-
Julian Hiscox
Understanding immunity to SARS-CoV2 infection
-
Katherine Kedzierska
Antibodies against Emerging Infectious Diseases -global collaborations
-
Erica Ollmann-Saphire
Break
1:10PM - 1:25PM
Monday, 9th November
Session 3: Innate Immunity
1:25PM - 2:25PM
Monday, 9th November
Chairs: Jose Villadangos & Olaf Rotzschke
Single cell mapping of human brain cancer reveals tumor-driven education education of tumor-associated leukocytes
-
Burkhard Becher
Talin1 sets the stage for TLR-mediated activation of dendritic cells
-
I-hsin Su
Insights into the requirements for long-term cytomegalovirus immunity
-
Mariapia Degli-Esposti
Break
2:25PM - 2:35PM
Monday, 9th November
Session 4: Virtual Poster Presentations
2:35PM - 3:25PM
Monday, 9th November
Chairs: Jose Villadangos & Laurent Renia
Polynucleotide immunotherapy for HPV associated oropharyngeal cancer
-
Ian H Frazer
Polymerized Amino Acids as a Self-Adjuvanting Delivery System for Vaccine against Group A Streptococcus
-
Mariusz Skwarczynski
Development an oral-delivery system for peptide vaccine against Group A
Streptococcus
-
Mohammad Omer Faruck
Development of Lipopeptide-based Adjuvants as Vaccine Candidates against Group A Streptococcus (GAS)
-
Farrhana Firdaus
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
-
Thi HO Nguyen
Immune correlates of COVID-19 severity and modulation with cyclooxygenase-2 inhibitors
-
Yi-Hao Chan
Immune landscape of 382-nt deleted SARS-CoV-2 reveals heightened adaptive response indicating prophylactic potential against COVID-19
-
Siew-Wai Fong
Two linear B cell epitopes on SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
-
Chek Meng Poh
An investigation of the T cell response against viruses through a structural lens
-
Stephanie Gras
Tuesday →